Follow the SMS Pharmaceuticals stock price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €33.4bn. The latest transaction was reported on 24 August 2026 (Acquisition). Among the most active insiders: N. Srilakshmi Padmini. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
SMS Pharmaceuticals es una empresa activa en el sector farmacéutico, especializada en la fabricación de productos químicos y medicamentos. Cotiza en el XBOM.